Advanced Search

Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2006 October;54(5) > Minerva Cardioangiologica 2006 October;54(5):673-7



A Journal on Heart and Vascular Diseases

Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752

Frequency: Bi-Monthly

ISSN 0026-4725

Online ISSN 1827-1618


Minerva Cardioangiologica 2006 October;54(5):673-7


Carotid artery stenting: where are we now?

Rabe K., Sievert H.

CardioVascular Center Frankfurt Sankt Katharinen, Frankfurt, Germany

Carotid artery disease is a frequent risk factor for ischemic stroke. Carotid endarterectomy was considered to be the standard treatment for high graded stenosis until carotid artery stenting (CAS) developed with promising results in early series and randomized trials. At present, stenting is supported in patients at high risk for surgery. Randomized trials analyzing low risk patient groups and studying the long-term results of CAS are necessary and partly underway. Although randomized trials are not yet available, current evidence suggests that cerebral protection devices reduce the number of neurological events. This review discusses the results of randomized trials and clinical series.

language: English


top of page